20 / May / 2026 Why Zika has nearly disappeared in Brazil—and why scientists are still concerned With microcephaly cases still being reported, Brazilian researchers have been mapping advances since 2015, hypotheses for the decline of Zika, and as-yet unanswered questions By Daniel Dieb
29 / April / 2026 Brazilian study shows COVID-19 can lead to profound hearing loss A combination of the effects of SARS-CoV-2, the inflammatory response, and intensive treatments may explain the serious health outcome By Arthur Almeida
28 / April / 2026 Unfinished buildings in China increase carbon emissions and health risks, study finds Study estimates waste of 485 million tons of materials, a 9.6% increase in the sector’s carbon intensity, and 2.6 million years of life lost to disability associated with China’s real estate crisis By Gabriela Monteiro
16 / April / 2026 Can social media impact your health? Case against Meta and YouTube reignites debate Researcher compares the impact of Big Tech to that of the tobacco industry and advocates for new regulatory framework to protect children and adolescents By Gabriela Monteiro
16 / April / 2026 Psyllium: Why do we still not fully understand its effects on the body? Used since antiquity, the compound can now be found in dietary supplements By Editorial staff
14 / April / 2026 Technology helps identify malaria transmission zones in Brazil By analyzing location data from the mobile phones of residents of Manaus, researchers were able to map high-risk areas with greater precision and speed By Arthur Almeida
10 / April / 2026 DATASUS: why Brazil collects so much health data—but still makes few decisions using it Open-access databases have put Brazil on the global map, but fragmentation and gaps make it difficult to turn information into health decisions By Marília Marasciulo
09 / April / 2026 Texas approves US$3 billion for a dementia research institute The initiative replicates a successful model for cancer research funding and could become one of the world’s largest funders of research on neurodegenerative diseases By Rodrigo de Oliveira Andrade
08 / April / 2026 What’s next for Latin American science? Experts gather in São Paulo to discuss the future Organized by Einstein, “Voices of Latin American Science” examines innovation, science policy, and the challenges facing research in the region By Editorial staff
07 / April / 2026 Agonists and antagonists: drugs to modulate body signals From asthma inhalers to monoclonal antibodies: how drugs “talk” to cells By Yasmim Cunha
